Conversion of stable renal transplant recipients from sandimmune to sang-35, a neoral-equivalent cyclosporine formulation, using a dose-adjusted method

By First M.R.   Weiskittel P.   Shah M.   Peddi V.R.   Canafax D.   Schroeder T.J.  

Transplantation Proceedings, Vol. 30, Iss. 8, 1998-12 ,pp. : 3955-3957

Elsevier

Access to resources Recommend Favorite

Conversion From Cyclosporine Sandimmune to Cyclosporine Neoral in the Stable Renal Transplant Population

By Griffin P.J.A.   Moore R.H.   Jurewicz W.A.   Lord R.H.H.   Webley Y.   Jenkins J.  

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 303-303

Elsevier

Access to resources Recommend Favorite

Comparative bioavailability of neoral and sandimmune in cardiac transplant recipients over 1 year

By Cooney G.F.   Jeevanandam V.   Choudhury S.   Feutren G.   Mueller E.A.   Eisen H.J.  

Transplantation Proceedings, Vol. 30, Iss. 5, 1998-08 ,pp. : 1892-1894

Elsevier

Access to resources Recommend Favorite

Cyclosporine neoral profiling in japanese renal transplant recipients

By Aikawa A.   Arai K.   Tajima E.   Kawamura T.   Ogiwara H.   Sakai K.   Mizuiri S.   Ohara T.   Hasegawa A.   Kosugi T.   Kusano A.   Matsuo K.   Obayashi M.   Kurokawa M.  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3142-3145

Elsevier

Access to resources Recommend Favorite

Conversion from sandimmune to neoral in renal transplant recipients: two-year experience

By Wilczek H.E.   &   9kesson P.   Warholm C.  

Transplantation Proceedings, Vol. 30, Iss. 5, 1998-08 ,pp. : 1753-1755

Elsevier

Access to resources Recommend Favorite